Dr. Maureen Okam Achebe is the Assistant Director for Hematology Integration at the Center for Integration Science. Dr. Achebe is Clinical Director of Hematology at Brigham and Women’s Hospital (BWH) and Clinical director of Hematology Services at Dana Farber Cancer Institute (DFCI). In these roles she devises strategies for clinical operations improvements and oversees all classical hematology patient care at BWH and DFCI. She is the director of the Comprehensive Sickle Cell Disease Center at BWH that delivers state-of-the-art care to adults with sickle cell disease (SCD). Dr. Achebe is deeply involved in the care of individuals with SCD in the US and internationally. She is the co-chair of the data subcommittee of the American Society of Hematology Consortium on newborn screening for SCD in Africa (CONSA) that seeks to demonstrate the benefits of screening and early intervention for SCD underway in seven countries in sub-Saharan Africa. She has represented ASH and CONSA at 2019 World Health Assembly side meeting in Geneva and at WHO Afro regional meetings in Brazzaville, Congo to advance support for the care of individuals with SCD worldwide. Dr. Achebe serves as a commissioner on the Lancet Non-Communicable Disease and Injuries (NCDI) Nigeria Poverty Commission as the sickle cell disease expert and guides the identification and prioritization of policies, interventions and integrated delivery platforms to effectively address and reduce SCD burden in the country. She is actively involved in clinical trials and translational research at BWH and was an investigator in the development of two of the most recently US FDA-approved drugs for SCD. She is Co-Director of the Harvard-MIT Health Sciences and Technology ICM: Hematology Clinic for Harvard Medical students. 

Dr. Achebe is a graduate of University of Port Harcourt medical school, specialty training in Hematology and Medical Oncology at Yale School of Medicine and is a graduate of Harvard T.H Chan School of Public Health. She is an Associate Professor of Medicine at Harvard Medical School.